Omeprazole-induced hepatotoxicity? A case report

Pharmacoepidemiology and Drug Safety

Volumn 7, Issue SUPPL. 1, 1998, Pages

  Christe, C ^a   Stoller, R ^b   Vogt, N ^a  

^a Hopital de Geriatrie   (Switzerland)

^b Swiss Drug Regulatory Agency   (Switzerland)

Author keywords

Adverse drug reactions (ADRs); Anti ulcer agents; Liver diseases; Omeprazole

Indexed keywords

ACENOCOUMAROL; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FUROSEMIDE; GAMMA GLUTAMYLTRANSFERASE; GLIPIZIDE; ISOSORBIDE DINITRATE; LACTATE DEHYDROGENASE; OMEPRAZOLE;

AGED; CASE REPORT; CHOLESTATIC HEPATITIS; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIVER FAILURE; LIVER TOXICITY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH ULCER;

EID: 0031831068     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199808)7:1+3.0.CO;2-2     Document Type: Conference Paper

References (6)

1. Garcia Rodriguez, L. A., Wallander, M. A. and Stricker, B. H. Ch. The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs. British Journal of Clinical Pharmacology 1997; 43: 183-188.
2. Solvell, L. The clinical safety of omeprazole. Digestion 1990; 47 (Suppl. 1): 59-63.
3. Yeomans, N. D. Omeprazole: short- and long-term safety. Adverse Drug Reactions and Toxicology Review 1994; 13(3): 145-156.
4. Maton, P. N., Vinayek, R., Frucht, H., et al. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study. Gastroenterology 1989; 97: 827-836.
5. Lauritsen, K., Simon, J. R., Bytzer, P., et al. Effect of omeprazole and cimetidine on duodenal ulcer. New England Journal of Medicine 1985; 312: 958-961.
6. Jochem, V., Kirkpatrick, R., Greenson, J., Brogan, M., Sturgis, T. and Cook-Glenn, C. Fulminant hepatic failure related to omeprazole. American Journal of Gastroenterology 1992; 87(4): 523-525.